These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36915750)

  • 21. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
    Khaitan D; Dinger ME; Mazar J; Crawford J; Smith MA; Mattick JS; Perera RJ
    Cancer Res; 2011 Jun; 71(11):3852-62. PubMed ID: 21558391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis.
    Gao H; Li X; Zhan G; Zhu Y; Yu J; Wang J; Li L; Wu W; Liu N; Guo X
    Cell Cycle; 2019 Jun; 18(12):1393-1406. PubMed ID: 31122127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell.
    Li Y; Liao Z; Wang R; Liang Z; Lin Z; Deng S; Chen L; Liu Z; Feng S
    PeerJ; 2022; 10():e13221. PubMed ID: 35378932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC.
    Ye Y; Gu J; Liu P; Wang H; Jiang L; Lei T; Yu S; Han G; Wang Z
    Onco Targets Ther; 2020; 13():2783-2793. PubMed ID: 32308413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.
    Shen F; Cai WS; Feng Z; Chen JW; Feng JH; Liu QC; Fang YP; Li KP; Xiao HQ; Cao J; Xu B
    Oncotarget; 2017 Feb; 8(9):14479-14486. PubMed ID: 27391336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.
    Wu H; Wang Y; Chen T; Li Y; Wang H; Zhang L; Chen S; Wang W; Yang Q; Chen C
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
    Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
    Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
    Peng W; Wu G; Fan H; Wu J; Feng J
    Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal transition.
    Cao D; Ding Q; Yu W; Gao M; Wang Y
    Onco Targets Ther; 2016; 9():5417-25. PubMed ID: 27621655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior.
    Xu J; Ding R; Xu Y
    Am J Transl Res; 2016; 8(12):5330-5337. PubMed ID: 28078006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay.
    Zhao L; Jiang L; Zhang M; Zhang Q; Guan Q; Li Y; He M; Zhang J; Wei M
    Oncogene; 2021 Jul; 40(30):4919-4929. PubMed ID: 34163032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.
    Zhang Y; Chen H; Yuan R; Wang Y; Zhang D; Zeng Q; Jiang W; Zhang R; Chen T; Chai C; Guo B
    Mol Carcinog; 2023 Jul; 62(7):1009-1024. PubMed ID: 37042573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
    Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
    Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis.
    Xie HW; Wu QQ; Zhu B; Chen FJ; Ji L; Li SQ; Wang CM; Tong YS; Tuo L; Wu M; Liu ZH; Lv J; Shi WH; Cao XF
    Tumour Biol; 2014 Aug; 35(8):7743-54. PubMed ID: 24810925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
    Guo W; Zhong K; Wei H; Nie C; Yuan Z
    PLoS One; 2018; 13(2):e0193483. PubMed ID: 29489909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of long noncoding RNAs ANCR, TINCR, HOTTIP and SPRY4-IT1 in plasma of systemic sclerosis patients: SPRY4-IT1 as a novel biomarker of scleroderma and its subtypes.
    Abd-Elmawla MA; Hassan M; Elsabagh YA; Alnaggar ARLR; Senousy MA
    Cytokine; 2020 Sep; 133():155124. PubMed ID: 32442909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of long noncoding RNA SPRY4-IT1 modulates proliferation, migration, apoptosis, and network formation in trophoblast cells HTR-8SV/neo.
    Zou Y; Jiang Z; Yu X; Sun M; Zhang Y; Zuo Q; Zhou J; Yang N; Han P; Ge Z; De W; Sun L
    PLoS One; 2013; 8(11):e79598. PubMed ID: 24223182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.